Search

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiorgan manifestations, including pleuropulmonary involvement (20–90%). The precise mechanism of pleuropulmonary involvement in SLE is not well-understood; however, systemic type 1 interferons, circulating immune complexes, and neutrophils seem to play essential roles. There are eight types of pleuropulmonary involvement: lupus pleuritis, pleural effusion, acute lupus pneumonitis, shrinking lung syndrome, interstitial lung disease, diffuse alveolar hemorrhage (DAH), pulmonary arterial hypertension, and pulmonary embolism. DAH has a high mortality rate (68–75%). The diagnostic tools for pleuropulmonary involvement in SLE include chest X-ray (CXR), computed tomography (CT), pulmonary function tests (PFT), bronchoalveolar lavage, biopsy, technetium-99m hexamethylprophylene amine oxime perfusion scan, and (18)F-fluorodeoxyglucose positron emission tomography. An approach for detecting pleuropulmonary involvement in SLE includes high-resolution CT, CXR, and PFT. Little is known about specific therapies for pleuropulmonary involvement in SLE. However, immunosuppressive therapies such as corticosteroids and cyclophosphamide are generally used. Rituximab has also been successfully used in three of the eight pleuropulmonary involvement forms: lupus pleuritis, acute lupus pneumonitis, and shrinking lung syndrome. Pleuropulmonary manifestations are part of the clinical criteria for SLE diagnosis. However, no review article has focused on the involvement of pleuropulmonary disease in SLE. Therefore, this article summarizes the literature on the epidemiology, pathogenesis, diagnosis, and management of pleuropulmonary involvement in SLE. [ABSTRACT FROM AUTHOR]

Making high-quality raw materials is the key to open the versatile potential of next generation materials. All-inorganic CsPbX3 (X: Cl−, Br−, and/or I−) perovskite quantum dots (PQDs) have been applied in various optoelectronic devices, such as photocatalysis, hydrogen evolution, solar cells, and light-emitting diodes, due to their outstanding photophysical properties, such as high photoluminescence quantum yield (PLQY), absorption cross-section, efficient charge separation, and so on. Specifically, for further improvement of the PLQY of the PQDs, it is essential to diminish the non-radiative charge recombination processes. In this work, we approached two ways to control the non-radiative charge recombination processes through synthetic and post-synthetic processes. Firstly, we proposed how refinement of the conventional recrystallization process for PbI2 contributes to higher PLQY of the PQDs. Secondly, after halide exchange from CsPbI3 PQDs to CsPbBr3, through an in situ spectroelectrochemical setup, we monitored the positive correlation between bromide deposition of on the surface of the perovskite and photoluminescence improvement of the CsPbBr3 perovskite film through electrodeposition. These two strategies could provide a way to enhance the photophysical properties of the perovskites for application to various perovskite-based optoelectronic devices. [ABSTRACT FROM AUTHOR]

In modern society, high-quality material development and a large stable supply are key to perform frontier research and development. However, there are negative issues to address to utilize high-quality resources with a large stable supply for research, such as economic accessibility, commercialization, and so on. One of the cutting-edge research fields, perovskite-related research, usually requires high-quality chemicals with outstanding purity (>99%). We developed an economically feasible PbI2 precursor with around 1/20 cost-down for perovskite/perovskite quantum dots through recrystallization and/or hydrothermal purification. Following the methodology, the quantum dots from both as-prepared and purified PbI2 demonstrated identical photophysical properties, with a photoluminescence quantum yield (PLQY) of 52.61% using the purified PbI2 vs. 45.83% PLQY using commercial PbI2. The role of hydrothermal energy was also checked against the problematic PbI2, and we checked whether the hydrothermal energy could contribute to the hindrance of undesired particle formation in the precursor solution, which enables them to form enlarged grain size from 179 ± 80 to 255 ± 130 nm for higher photoconversion efficiency of perovskite solar cells from 14.77 ± 1.82% to 15.18 ± 1.92%. [ABSTRACT FROM AUTHOR]